Cepheid Logo
Request Info
Location / Language

{{headingText}}

{{paragraphText}}

{{continueBtnLabel}}
{{initials}}
Main Menu
Location / Language

{{headingText}}

{{paragraphText}}

{{continueBtnLabel}}

Request Info
Request Info

Xpert® MRSA/SA SSTI

Order & Support
MRSA/SA SSTI computer generated depiction.
Detect MRSA & SA Skin and Soft Tissue Infections in 62 minutes

The Need

an ill woman listens to a physician
  • Surgical-site infections (SSIs) are a significant cause of morbidity and mortality1
  • S. aureus is one of the most common pathogens responsible for SSIs2
  • SSIs caused by MRSA lead to worse clinical outcomes vs less resistant pathogens2
  • The use of inappropriate initial antibiotic treatment can be associated with adverse clinical outcomes and increased length of stay3
(1) Mengistu DA, Alemu A, Abdukadir AA, Mohammed Husen A, Ahmed F, Mohammed B, Musa I. Global Incidence of Surgical Site Infection Among Patients: Systematic Review and Meta-Analysis. Inquiry. 2023 Jan-Dec;60:469580231162549. doi: 10.1177/00469580231162549. PMID: 36964747; PMCID: PMC10041599.
(2) Seidelman JL, Mantyh CR, Anderson DJ. Surgical Site Infection Prevention: A Review. JAMA. 2023;329(3):244–252. doi:10.1001/jama.2022.24075
(3) Nathwani D, et al. Early clinical assessment of response to treatment of skin and soft-tissue infections: how can it help clinicians? Perspectives from Europe. Int J Antimicrob Agents. 2016

The Solution

The Xpert MRSA/SA SSTI test is a qualitative in vitro diagnostic test intended for the detection of Staphylococcus aureus (SA) and methicillin-resistant Staphylococcus aureus (MRSA) from skin and soft tissue infection swabs
  • Laboratory efficiencies with on-demand workflows requiring minimal hands-on time
  • Optimize therapy with informed decisions

The Impact

a smiling female doctor attends an elderly woman
  • Rapid detection enables more targeted antibiotic selection4
  • Patient management with informed treatment decisions.
  • Provides results in approximately 1 hour
(4) May LS, et al. A Randomized Clinical Trial Comparing Use of Rapid Molecular Testing for Staphylococcus aureus for Patients With Cutaneous Abscesses in the Emergency Department With Standard of Care. Infect Control Hosp Epidemiol. 2015

Connect To Better Outcomes

Request Info

Insights

Get More Insights